🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Sartorius Stedim Biotech (DIMp)

BATS Europe
Currency in EUR
180.70
0.00(0.00%)
Closed
DIMp Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
Fair Value
Day's Range
180.70185.25
52 wk Range
141.70280.40
Bid/Ask
166.55 / 171.60
Prev. Close
180.7
Open
185.25
Day's Range
180.7-185.25
52 wk Range
141.7-280.4
Volume
0
Average Volume (3m)
147
1-Year Change
-8.26%
Fair Value
Unlock
Fair Value Upside
Unlock
DIMp Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
220.67
Upside
+20.13%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Sartorius Stedim Biotech SA Company Profile

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

Employees
10662
Market
France

Compare DIMp to Peers and Sector

Metrics to compare
DIMp
Peers
Sector
Relationship
P/E Ratio
110.4x−1.8x−0.7x
PEG Ratio
−1.61−0.050.00
Price/Book
4.5x1.6x2.6x
Price / LTM Sales
6.5x3.5x3.2x
Upside (Analyst Target)
-46.0%47.0%
Fair Value Upside
Unlock16.3%8.3%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.68
Dividend Yield
0.37%
Industry Median 1.47%
Annualised payout
0.6900
Paid annually
5-Years Growth
-
Growth Streak

People Also Watch

24.94
TE
+0.56%
22.64
RUBF
+1.71%
99.20
BIOX
-2.07%
52.05
ERMT
-0.19%
15.305
VLLP
+1.06%

FAQ

What Is the Sartorius Stedim (DIMp) Stock Price Today?

The Sartorius Stedim stock price today is 180.70

What Stock Exchange Does Sartorius Stedim Trade On?

Sartorius Stedim is listed and trades on the BATS Europe stock exchange.

What Is the Stock Symbol for Sartorius Stedim?

The stock symbol for Sartorius Stedim is "DIMp."

Does Sartorius Stedim Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.37%.

What Is the Sartorius Stedim Market Cap?

As of today, Sartorius Stedim market cap is 17.89B.

What is Sartorius Stedim Earnings Per Share?

The Sartorius Stedim EPS is 1.68.

What Is the Next Sartorius Stedim Earnings Date?

Sartorius Stedim will release its next earnings report on 23 Jan 2025.

From a Technical Analysis Perspective, Is DIMp a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.